SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001213900-22-081139
Filing Date
2022-12-20
Accepted
2022-12-20 06:37:47
Documents
7
Effectiveness Date
2022-12-20

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 ea167930-s8pos_mesoblast.htm S-8 POS 79735
2 CONSTITUTION OF MESOBLAST LIMITED ea167930ex3-1_mesoblast.htm EX-3.1 595757
3 OPINION OF RIMON LAW PTY LTD ea167930ex5-1_mesoblast.htm EX-5.1 9175
4 CONSENT OF PRICEWATERHOUSECOOPERS, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea167930ex23-1_mesoblast.htm EX-23.1 2024
5 EMPLOYEE SHARE OPTION PLAN, AS AMENDED ON OCTOBER 17, 2022 ea167930ex99-1_mesoblast.htm EX-99.1 321972
6 GRAPHIC ex3-1_001.jpg GRAPHIC 3370
7 GRAPHIC ex5-1_001.jpg GRAPHIC 2926
  Complete submission text file 0001213900-22-081139.txt   1018661
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: S-8 POS | Act: 33 | File No.: 333-240107 | Film No.: 221472808
SIC: 2836 Biological Products, (No Diagnostic Substances)